 3i Infotech Limited allots 3,77,08,165 equity shares on rights basis, Issue oversubscribed 1.45 times
3i Infotech Limited allots 3,77,08,165 equity shares on rights basis, Issue oversubscribed 1.45 times Reliance Power Ltd appoints retired IAS Officer Ms. Zohra Chatterji as Independent Director
Reliance Power Ltd appoints retired IAS Officer Ms. Zohra Chatterji as Independent Director Airfloa Rail Technology Ltd receives order worth Rs. 23.91 crores
Airfloa Rail Technology Ltd receives order worth Rs. 23.91 crores Macfos Ltd consolidated Q2FY26 net profit up QoQ at Rs. 5.10 crore
Macfos Ltd consolidated Q2FY26 net profit up QoQ at Rs. 5.10 crore Jasch Gauging Technologies Ltd Q2 FY2025-26 net profit at Rs. 5.13 crore
Jasch Gauging Technologies Ltd Q2 FY2025-26 net profit at Rs. 5.13 crore 
              The Board of Directors of Bal Pharma Ltd at its meeting held on April 13, 2016, has approved the allotment of 13,00,000 equity shares of Rs. 10/- each with a premium of Rs. 52/- per share of the Company on preferential basis to the investors who has exercised the conversion option on 13,00,000 warrants subscribed by them.
With this allotment, the paid up equity share capital of the Company has enhanced to Rs. 14,17,23,720/- divided into 1,41,72,372 equity shares of Rs. 10 each.
Shares of BAL PHARMA LTD. was last trading in BSE at Rs.103.7 as compared to the previous close of Rs. 102.1. The total number of shares traded during the day was 30464 in over 513 trades.
The stock hit an intraday high of Rs. 106.9 and intraday low of 102.6. The net turnover during the day was Rs. 3197216.